Bio-Inspired Nanomedicine An Emerging Trend For Drug Targeting Into Cancer Cells

MD. HABBAN AKHTER | August 14, 2019

article image
The mortality rate increases day-to-day due to most vulnerable disease cancer universally and current therapeutic mitigation bears high levels of diversity and complexity in therapeutic regime. The systemic application of chemotherapeutic agents often accompanied with serious side and adverse effects along with normal cell toxicity. The chemotherapy is often associated with poor selectivity; lack of uniform biodistribution, inefficient access of drug to tumor site along with multidrug resistance. Despite this chemotherapy in cancer patient assorted with severe side effect, variation in drug plasma profile, dose dumping, and patient incompliance. Due to considerable interest and growing scope of nanotechnology, a tremendous breakthrough has come in search of cancer disease, their origin and development, led to the better treatment and diagnosis

Spotlight

Pharma Group Holding

Pharma Group is strongly committed to providing its customer base with a diversified portfolio of value-added and reputable brands through innovative marketing and investment strategies for the Levant area: Lebanon, Syria, Jordan and Iraq.

OTHER ARTICLES

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

Comparing HydroxyChloroquine Trials

Article | April 1, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

Spotlight

Pharma Group Holding

Pharma Group is strongly committed to providing its customer base with a diversified portfolio of value-added and reputable brands through innovative marketing and investment strategies for the Levant area: Lebanon, Syria, Jordan and Iraq.

Events